BlackRock Group’s West Pharmaceutical WST Stock Holding History

BlackRock Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$5.11M	Buy	60,209 +4,524	+8%	+$356K	﹤0.01%	1186
2016 Q3	$4.15M	Sell	55,685 -22,807	-29%	-$1.81M	﹤0.01%	1199
2016 Q2	$5.96M	Buy	78,492 +28,721	+58%	+$2.09M	﹤0.01%	1035
2016 Q1	$3.45M	Buy	49,771 +9,045	+22%	+$544K	﹤0.01%	1234
2015 Q4	$2.45M	Sell	40,726 -1,303	-3%	-$78.4K	﹤0.01%	1377
2015 Q3	$2.27M	Sell	42,029 -41,488	-50%	-$2.42M	﹤0.01%	1425
2015 Q2	$4.85M	Buy	83,517 +14,119	+20%	+$788K	﹤0.01%	1151
2015 Q1	$4.18M	Buy	69,398 +3,668	+6%	+$195K	﹤0.01%	1176
2014 Q4	$3.5M	Sell	65,730 -23	-0%	-$1.15K	﹤0.01%	1249
2014 Q3	$2.94M	Sell	65,753 -1,206	-2%	-$51.2K	﹤0.01%	1270
2014 Q2	$2.82M	Sell	66,959 -40,069	-37%	-$1.72M	﹤0.01%	1318
2014 Q1	$4.71M	Sell	107,028 -1,139	-1%	-$53.6K	﹤0.01%	1127
2013 Q4	$5.31M	Sell	108,167 -13,637	-11%	-$638K	﹤0.01%	1060
2013 Q3	$5.01M	Buy	121,804 +37,590	+45%	+$1.43M	﹤0.01%	1063
2013 Q2	$2.96M	Buy	+84,214	New	+$2.77M	﹤0.01%	1132

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock Group's WST Position: Q4 2016 in Review

BlackRock Group increased its West Pharmaceutical (WST) stake by 8.1% in Q4 2016, buying an estimated $356K and bringing the position to 60,209 shares worth $5.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1186.

BlackRock Group first reported a position in WST in Q2 2013 and has held it in 15 quarters since. The position peaked at $5.96M in Q2 2016. 288 funds tracked by Wall St. Rank hold WST as of Q4 2016.

BlackRock Group held 60,209 shares of West Pharmaceutical worth $5.11M as of Q4 2016.
BlackRock Group bought 4,524 West Pharmaceutical shares in Q4 2016, an estimated $356K.
West Pharmaceutical made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1186 holding.
BlackRock Group first reported a position in West Pharmaceutical in Q2 2013 and has held it in 15 quarters since.
BlackRock Group's West Pharmaceutical position peaked at $5.96M in Q2 2016.
288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.